Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Inv. presentation
Quarterly results
Director departure
|
|
Emergent BioSolutions Inc. (EBS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Fowler Neal Franklin (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 118,670 shares
@ $0 |
|
| 10/05/2023 |
4
| DeGolyer Donald W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 118,670 shares
@ $0 |
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2023 |
4
| Zoon Kathryn C (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Hauer Jerome M (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Richard Ronald (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Katkin Keith (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Harsanyi Zsolt (Chairman) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 05/30/2023 |
4
| Dayal Sujata Tyagi (Director) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 33,847 shares
@ $0 |
|
| 03/06/2023 |
4
| Havey Adam (EVP, Business Operations) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 6,154 shares
@ $0
Granted 12,308 shares
@ $0
Granted 12,308 options to buy
@ $12.06, valued at
$148.4k
|
|
| 03/06/2023 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 19,231 shares
@ $0
Granted 38,462 shares
@ $0
Granted 38,462 options to buy
@ $12.06, valued at
$463.9k
|
|
| 03/06/2023 |
4
| Glessner Coleen (EVP, Quality & Ethics, and CPL) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 3,846 shares
@ $0
Granted 7,692 shares
@ $0
Granted 7,692 options to buy
@ $12.06, valued at
$92.8k
|
|
| 03/06/2023 |
4
| Williams Paul Anthony (SVP, Products Business) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 1,154 shares
@ $0
Granted 2,308 shares
@ $0
Granted 2,308 options to buy
@ $12.06, valued at
$27.8k
|
|
| 03/06/2023 |
4
| LINDAHL RICHARD S (EVP, CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 6,154 shares
@ $0
Granted 12,308 shares
@ $0
Granted 12,308 options to buy
@ $12.06, valued at
$148.4k
|
|
| 03/06/2023 |
4
| Fox Jennifer Lynne (EVP, Ext Aff, GC, Corp Sec) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 6,154 shares
@ $0
Granted 12,308 shares
@ $0
Granted 12,308 options to buy
@ $12.06, valued at
$148.4k
|
|
| 03/02/2023 |
4
| Fox Jennifer Lynne (EVP, Ext Aff, GC, Corp Sec) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,005 shares
@ $12.38, valued at
$12.4k
|
|
| 03/02/2023 |
4
| Williams Paul Anthony (SVP, Products Business) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 371 shares
@ $12.38, valued at
$4.6k
|
|
| 03/02/2023 |
4
| SARAN ATUL (EVP, Chief Strat & Dev Officer) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 971 shares
@ $12.38, valued at
$12k
|
|
| 03/02/2023 |
4
| LINDAHL RICHARD S (EVP, CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,074 shares
@ $12.38, valued at
$13.3k
|
|
| 03/02/2023 |
4
| Strei Katherine (EVP, Chief HR Officer) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 690 shares
@ $12.38, valued at
$8.5k
|
|
| 03/02/2023 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 3,226 shares
@ $12.38, valued at
$39.9k
|
|
| 03/02/2023 |
4
| Havey Adam (EVP, Business Operations) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 998 shares
@ $12.38, valued at
$12.4k
|
|
| 02/27/2023 |
4
| Strei Katherine (EVP, Chief HR Officer) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 352 shares
@ $14.3, valued at
$5k
Paid exercise price by delivering 654 shares
@ $13.71, valued at
$9k
|
|
| 02/27/2023 |
4
| SARAN ATUL (EVP, Chief Strat & Dev Officer) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 365 shares
@ $14.3, valued at
$5.2k
Paid exercise price by delivering 845 shares
@ $13.71, valued at
$11.6k
|
|
| 02/27/2023 |
4
| Williams Paul Anthony (SVP, Products Business) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 89 shares
@ $14.3, valued at
$1.3k
|
|
| 02/27/2023 |
4
| LINDAHL RICHARD S (EVP, CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 444 shares
@ $14.3, valued at
$6.3k
Paid exercise price by delivering 977 shares
@ $13.71, valued at
$13.4k
|
|
| 02/27/2023 |
4
| Fox Jennifer Lynne (EVP, Ext Aff, GC, Corp Sec) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 231 shares
@ $14.3, valued at
$3.3k
Paid exercise price by delivering 258 shares
@ $13.71, valued at
$3.5k
|
|
| 02/27/2023 |
4
| Havey Adam (EVP, Business Operations) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 432 shares
@ $14.3, valued at
$6.2k
Paid exercise price by delivering 812 shares
@ $13.71, valued at
$11.1k
|
|
| 02/27/2023 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,428 shares
@ $14.3, valued at
$20.4k
Paid exercise price by delivering 1,591 shares
@ $13.71, valued at
$21.8k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|